NDC 0409-1467 – Nalbuphine Hydrochloride

Nalbuphine Hydrochloride 20 mg/mL · Injection, Solution · Intramuscular, Intravenous, Subcutaneous

Human Prescription Drug 1 recall

Product NDC0409-1467

Product details

Brand name
Nalbuphine Hydrochloride
Generic name
Nalbuphine Hydrochloride
Labeler
Hospira, Inc.
Dosage form
Injection, Solution
Route
Intramuscular, Intravenous, Subcutaneous
Marketing category
ANDA · ANDA070918
Marketed since
May 16, 2005
Listing expires
December 31, 2026
Pharmacologic class
Opioid Agonist/Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Nalbuphine hydrochloride →

Package NDC codes (1)

Package NDCDescriptionSince
0409-1467-0125 CARTON in 1 CASE (0409-1467-01) / 1 VIAL, MULTI-DOSE in 1 CARTON (0409-1467-61) / 10 mL in 1 VIAL, MULTI-DOSEMay 16, 2005

Recalls mentioning this NDC

Other Nalbuphine hydrochloride products